Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 53 Records) |
| Query Trace: Glioma and CDKN2A[original query] |
|---|
| The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer. Journal of Cancer 2019 8 10 (17): 4123-4131. Xu Jin-Zhi, Wang Wen-Quan, Zhang Wu-Hu, Xu Hua-Xiang, Gao He-Li, Zhang Shi-Rong, Wu Chun-Tao, Li Shuo, Li Hao, Xu Jin, Yu Xian-Jun, Liu Lia |
| Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features. Scientific reports 2019 Nov 9 (1): 16058. Zhang Longbo, Liu Zhiqiang, Li Jin, Huang Tianxiang, Wang Ying, Chang Lianpeng, Zheng Wenjie, Ma Yujie, Chen Fenghua, Gong Xuan, Yuan Qianying, Teaw Shannon, Fang Xinqi, Song Tao, Huo Lei, Li Xi, Xia Xuefeng, Liu Zhixiong, Wu J |
| Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Molecular biology reports 2019 11 47 (2): 877-886. Viana-Pereira Marta, Moreno Daniel Antunes, Linhares Paulo, Amorim Júlia, Nabiço Rui, Costa Sandra, Vaz Rui, Reis Rui Manu |
| Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis. Oncology letters 2019 Nov 18 (5): 5163-5172. Zhou Cong-Ya, Gong Liu-Yun, Liao Rong, Weng Ning-Na, Feng Yao-Yue, Dong Yi-Ping, Zhu Hong, Zhao Ya-Qin, Zhang Yuan-Yuan, Zhu Qing, Han Su-X |
| A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer science 2020 Aug . Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Takajo Tomoko, Kirishima Mari, Hamada Taiji, Matsuo Kei, Fujio Shingo, Hanada Tomoko, Hosoyama Hiroshi, Yonenaga Masanori, Sakamoto Akihisa, Hiraki Tsubasa, Tanimoto Akihide, Yoshimoto Ko |
| Is it a new culprit? "TERT promoter mutation" in an aggressive pediatric pilocytic astrocytoma. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020 8 37 (3): 1003-1008. Francis Jacintha Vikeneswary, Tanr?kulu Bahattin, Danyeli Ayca Ersen, Özek M Mem |
| Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression. Journal of neuropathology and experimental neurology 2020 8 79 (9): 1011-1014. Dal Col Pierre, Poncet Delphine, Rivoirard Romain, Vassal François, Bernichon Emilie, Boutet Claire, Péoc'h Michel, Forest Fabi |
| The prognostic significance of p16 expression pattern in diffuse gliomas. Journal of pathology and translational medicine 2020 Dec . Park Jin Woo, Kang Jeongwan, Lim Ka Young, Kim Hyunhee, Kim Seong-Ik, Won Jae Kyung, Park Chul-Kee, Park Sung-H |
| Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas. Clinical neuropathology 2020 Dec . Dono Antonio, Zhu Ping, Zorofchian Soheil, Takayasu Takeshi, Quezado Martha M, Rios Adan, Powers Astin, Esquenazi Yoshua, Ballester Leomar |
| Integrated genotype-phenotype analysis of long-term epilepsy-associated ganglioglioma. Brain pathology (Zurich, Switzerland) 2021 8 32 (1): e13011. Wang Yujiao, Wang Leiming, Blümcke Ingmar, Zhang Weiwei, Fu Yongjuan, Shan Yongzhi, Piao Yueshan, Zhao Guogua |
| Molecular diagnostics helps to identify distinct subgroups of spinal astrocytomas. Acta neuropathologica communications 2021 7 9 (1): 119. Biczok Annamaria, Strübing Felix L, Eder Julia M, Egensperger Rupert, Schnell Oliver, Zausinger Stefan, Neumann Julia E, Herms Jochen, Tonn Joerg-Christian, Dorostkar Mario |
| Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis. Cancer management and research 2021 5 13 3573-3588. Zeng Chun, Wang Jing, Li Mingwei, Wang Huina, Lou Feng, Cao Shanbo, Lu Chang |
| BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
| Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-oncology 2021 4 23 (9): 1547-1559. Tesileanu C Mircea S, van den Bent Martin J, Sanson Marc, Wick Wolfgang, Brandes Alba A, Clement Paul M, Erridge Sara C, Vogelbaum Michael A, Nowak Anna K, Baurain Jean F, Mason Warren P, Wheeler Helen, Chinot Olivier L, Gill Sanjeev, Griffin Matthew, Rogers Leland, Taal Walter, Rudà Roberta, Weller Michael, McBain Catherine, van Linde Myra E, Sabedot Thais S, Hoogstrate Youri, von Deimling Andreas, de Heer Iris, van IJcken Wilfred F J, Brouwer Rutger W W, Aldape Kenneth, Jenkins Robert B, Dubbink Hendrikus J, Kros Johan M, Wesseling Pieter, Cheung Kin Jip, Golfinopoulos Vassilis, Baumert Brigitta G, Gorlia Thierry, Noushmehr Houtan, French Pim |
| Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma. Molecular biology reports 2022 Sep . Youn Byeong Ju, Cheong Hyun Sub, Namgoong Suhg, Kim Lyoung Hyo, Baek In Ki, Kim Jeong-Hyun, Yoon Seon-Jin, Kim Eui Hyun, Kim Se Hoon, Chang Jong Hee, Kim Sun Ho, Shin Hyoung D |
| Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel. Neurologia medico-chirurgica 2022 8 62 (9): 391-399. Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Fujio Shingo, Kirishima Mari, Takigawa Kosuke, Hata Nobuhiro, Toh Keita, Yamamoto Junkoh, Hanaya Ryosuke, Tanimoto Akihide, Yoshimoto Ko |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. Life (Basel, Switzerland) 2022 Jun 12 (7): . Guarnaccia Maria, Guarnaccia Laura, La Cognata Valentina, Navone Stefania Elena, Campanella Rolando, Ampollini Antonella, Locatelli Marco, Miozzo Monica, Marfia Giovanni, Cavallaro Sebastia |
| Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (11): 2440-2448. Draaisma Kaspar, Tesileanu C Mircea S, de Heer Iris, Klein Martin, Smits Marion, Reijneveld Jaap C, Clement Paul M, de Vos Filip Y F, Wick Antje, Mulholland Paul J, Taphoorn Martin J B, Weller Michael, Chinot Olivier L, Kros Johan M, Verschuere Tina, Coens Corneel, Golfinopoulos Vassilis, Gorlia Thierry, Idbaih Ahmed, Robe Pierre A, van den Bent Martin J, French Pim |
| High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13. Acta neuropathologica 2022 2 143 (3): 403-414. Pratt Drew, Abdullaev Zied, Papanicolau-Sengos Antonios, Ketchum Courtney, Panneer Selvam Pavalan, Chung Hye-Jung, Lee Ina, Raffeld Mark, Gilbert Mark R, Armstrong Terri S, Pytel Peter, Borys Ewa, Klonoski Joshua M, McCord Matthew, Horbinski Craig, Brat Daniel, Perry Arie, Solomon David, Eberhart Charles, Giannini Caterina, Quezado Martha, Aldape Kenne |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| A prognostic risk model for glioma patients by systematic evaluation of genomic variations. iScience 2022 12 25 (12): 105681. Zhang Baifeng, Wan Weiqing, Li Zibo, Gao Zhixian, Ji Nan, Xie Jian, Wang Junmei, Wang Bin, Lai-Wan Kwong Dora, Guan Xinyuan, Gao Shengjie, Zhao Yuanli, Lu Youyong, Zhang Liwei, Rodland Karin D, Tsang Shirley |
| Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1. Acta neuropathologica 2022 10 145 (1): 71-82. Cimino Patrick J, Ketchum Courtney, Turakulov Rust, Singh Omkar, Abdullaev Zied, Giannini Caterina, Pytel Peter, Lopez Giselle Yvette, Colman Howard, Nasrallah MacLean P, Santi Mariarita, Fernandes Igor Lima, Nirschl Jeff, Dahiya Sonika, Neill Stewart, Solomon David, Perez Eilis, Capper David, Mani Haresh, Caccamo Dario, Ball Matthew, Badruddoja Michael, Chkheidze Rati, Camelo-Piragua Sandra, Fullmer Joseph, Alexandrescu Sanda, Yeaney Gabrielle, Eberhart Charles, Martinez-Lage Maria, Chen Jie, Zach Leor, Kleinschmidt-DeMasters B K, Hefti Marco, Lopes Maria-Beatriz, Nuechterlein Nicholas, Horbinski Craig, Rodriguez Fausto J, Quezado Martha, Pratt Drew, Aldape Kenne |
| Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis. Frontiers in oncology 2023 9 13 1180099. Yaqi Wu, Jun Zhou, Jun Zhang, Zhijian Tang, Xi Chen, Lulu Huang, Shengwen Liu, Hong Chen, Yu Wa |
| Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence. Brain tumor pathology 2023 3 . Tamura Ryota, Iwanami Akio, Ohara Kentaro, Nishimoto Masaaki, Pareira Eriel Sandika, Miwa Tomoru, Tsuzaki Naoko, Kuranari Yuki, Morimoto Yukina, Toda Masahiro, Okano Hideyuki, Nakamura Masaya, Yoshida Kazunari, Sasaki Hika |
| Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
| A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients. Neuro-oncology 2024 7 . Mary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, Jayne Vogelzang, Cecilia Sousa, Will Pisano, Jack Geduldig, Varun Bhave, Joseph Driver, Pei-Chi Kao, Alana McGovern, Clement Ma, Ashley S Margol, Kristina Cole, Amy Smith, Stewart Goldman, Kristiyana Kaneva, Ai Lien Truong, Kellie J Nazemi, Matthew D Wood, Karen D Wright, Wendy B London, Katherine E Warren, Patrick Y Wen, Wenya Linda Bi, Sanda Alexandrescu, David A Reardon, Keith L Ligon, Kee Kiat Y |
| Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype. Acta neuropathologica 2024 4 147 (1): 68. Farshad Nassiri, Andrew Ajisebutu, Vikas Patil, Yasin Mamatjan, Jeff Liu, Justin Z Wang, Mathew R Voisin, Romina Nejad, Sheila Mansouri, Shirin Karimi, Ankur Chakravarthy, Eric Chen, Daniel D De Carvalho, Kenneth Aldape, Gelareh Zad |
| Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma. Biochemical and biophysical research communications 2024 4 711 149894. Ji Wang, Yantin Liu, Min Qian, Wen Xu, Jianfeng Chen, Yuanguo Deng, Ran Luo, Jian Chen, Wenxue Jia, Longhu Liu, Chunlei Ti |
| CDKN2A Homozygous Deletion Is a Stronger Predictor of Outcome than IDH1/2-Mutation in CNS WHO Grade 4 Gliomas. Biomedicines 2024 10 12 (10): . Sang Hyuk Lee, Tae Gyu Kim, Kyeong Hwa Ryu, Seok Hyun Kim, Young Zoon K |
| GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
- Page last reviewed:Feb 1, 2024
- Content source: